首页> Diabetes, obesity & metabolism> Randomized, double-blind, phase III study to evaluate the efficacy and safety of once-daily treatment with alogliptin and metformin hydrochloride in Japanese patients with type 2 diabetes

Randomized, double-blind, phase III study to evaluate the efficacy and safety of once-daily treatment with alogliptin and metformin hydrochloride in Japanese patients with type 2 diabetes

导出原文传递

翻译打印收藏纠错

第一作者： Kaku, Kohei

作者： Kaku, Kohei ^[1] ; Sumino, Shuuji ^[2] ; Katou, Masafumi ; Nishiyama, Yuya ; Kinugawa, Yoshinobu

作者单位： Kawasaki Med Univ, Dept Internal Med, Okayama, Japan ^[1] Takeda Pharmaceut Co Ltd, Takeda Dev Ctr Japan, Osaka, Japan ^[2]

关键词 antidiabetic drug DPP-IV inhibitor metformin phase III study randomized trial type 2 diabetes

发布时间 2018-11-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Diabetes, obesity & metabolism

2017年19卷3期

463-467页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Diabetes, obesity & metabolism

2017年19卷3期

463-467页

检索历史清除

Randomized, double-blind, phase III study to evaluate the efficacy and safety of once-daily treatment with alogliptin and metformin hydrochloride in Japanese patients with type 2 diabetes

Diabetes, obesity & metabolism

相似文献

同项目论文

Diabetes, obesity & metabolism

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Randomized, double-blind, phase III study to evaluate the efficacy and safety of once-daily treatment with alogliptin and metformin hydrochloride in Japanese patients with type 2 diabetes

Diabetes, obesity & metabolism

相似文献

同项目论文

Diabetes, obesity & metabolism

相关期刊

检索历史清除